论文部分内容阅读
慢性活动性肝炎(简称慢活肝)的治疗是医学领域中最混乱问题之一。早在1960年就有人认为慢活肝是一种自身免疫性疾病,而试用皮质类固醇和其他细胞毒药物。最初报道认为这些药物有效,以后认识其过程有很大变化,因此使用这些药物的热忱也就逐渐减少。有人曾进行三组对照试验。现将有关情况简介如下。第一组试验:伦敦 Royal Free 医院在1963～1967年,将具有慢活肝临床和生化特
Treatment of chronic active hepatitis (referred to as slow living liver) is one of the most chaotic problems in the medical field. As early as 1960, it was suggested that slow living liver is an autoimmune disease, while the trial of corticosteroids and other cytotoxic drugs. Initial reports suggested that these drugs were effective and that subsequent knowledge of their processes varied greatly, and the enthusiasm for the use of these drugs also diminished. Someone has conducted three groups of controlled trials. The relevant briefings are as follows. The first group of trials: London Royal Free Hospital in 1963 to 1967, will have a slow liver clinical and biochemical